Ignite Creation Date:
2025-12-25 @ 3:46 AM
Ignite Modification Date:
2026-03-25 @ 6:18 AM
Study NCT ID:
NCT02165202
Status:
COMPLETED
Last Update Posted:
2018-08-27
First Post:
2014-05-21
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Phase II Safety and Acceptability of an Investigational Injectable Product, TMC278LA, for Pre-Exposure Prophylaxis
Sponsor:
PATH
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-10
Start Date Type:
None
Primary Completion Date:
2015-04-13
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-03-09
Completion Date Type:
ACTUAL
First Submit Date:
2014-05-21
First Submit QC Date:
None
Study First Post Date:
2014-06-17
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2018-07-02
Results First Submit QC Date:
None
Results First Post Date:
2018-07-26
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-07-27
Last Update Post Date:
2018-08-27
Last Update Post Date Type:
ACTUAL